Nifty 17401.65 (1.37%)
Sensex 58461.29 (1.35%)
Nifty Bank 36508.25 (0.39%)
Nifty IT 36157.85 (2.06%)
Nifty Financial Services 17982.9 (1.26%)
Adani Ports 739.10 (4.40%)
Asian Paints 3180.60 (1.35%)
Axis Bank 676.10 (-0.52%)
B P C L 378.85 (2.74%)
Bajaj Auto 3328.40 (2.43%)
Bajaj Finance 7180.50 (2.01%)
Bajaj Finserv 17758.15 (2.16%)
Bharti Airtel 732.55 (1.43%)
Britannia Inds. 3578.50 (1.22%)
Cipla 921.25 (-0.74%)
Coal India 159.30 (2.41%)
Divis Lab. 4777.30 (0.53%)
Dr Reddys Labs 4662.75 (1.22%)
Eicher Motors 2451.55 (0.54%)
Grasim Inds 1723.85 (2.63%)
H D F C 2807.80 (3.85%)
HCL Technologies 1184.70 (2.42%)
HDFC Bank 1525.75 (1.40%)
HDFC Life Insur. 705.30 (1.65%)
Hero Motocorp 2472.70 (1.00%)
Hind. Unilever 2383.30 (1.64%)
Hindalco Inds. 432.10 (1.69%)
I O C L 120.65 (2.51%)
ICICI Bank 722.40 (-0.73%)
IndusInd Bank 945.55 (1.27%)
Infosys 1748.25 (1.94%)
ITC 225.45 (1.60%)
JSW Steel 646.75 (1.50%)
Kotak Mah. Bank 1964.25 (0.56%)
Larsen & Toubro 1789.20 (0.18%)
M & M 849.55 (1.78%)
Maruti Suzuki 7324.95 (0.71%)
Nestle India 19503.20 (0.54%)
NTPC 128.70 (0.78%)
O N G C 144.00 (1.23%)
Power Grid Corpn 214.50 (3.52%)
Reliance Industr 2482.85 (0.64%)
SBI Life Insuran 1188.05 (1.99%)
Shree Cement 26289.80 (0.76%)
St Bk of India 477.00 (0.36%)
Sun Pharma.Inds. 766.25 (2.80%)
Tata Consumer 773.25 (0.06%)
Tata Motors 479.10 (0.81%)
Tata Steel 1112.40 (2.76%)
TCS 3642.90 (1.82%)
Tech Mahindra 1629.65 (2.65%)
Titan Company 2386.50 (1.11%)
UltraTech Cem. 7323.20 (0.01%)
UPL 698.20 (1.12%)
Wipro 646.80 (1.89%)
INFY

Biofil Chemicals & Pharma..

₹60.05
Not a customer?

Open free demat account
& trade instantly

Investment Ratings

As per analysts rating in the last 6 months, the recommendation is to HOLD Biofil Chemicals

  • Master Rating:
  • Biofil Chemicals & Pharmaceuticals has an operating revenue of Rs. 36.54 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 5% is okay, ROE of 7% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 22 which is a POOR score indicating inconsistency in earnings, a RS Rating of 3 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 162 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Biofil Chemicals & Pharmaceuticals Ltd Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Ratings

Eps And Sales Estimates

Biofil Chemicals & Pharmaceuticals Ltd Synopsis

NSE-Medical-Ethical Drugs

Biofil Chemicals belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 35.75 Cr. and Equity Capital is Rs. 16.27 Cr. for the Year ended 31/03/2021. Biofil Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 04/01/1985 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L24233MP1985PLC002709 and registration number is 002709.
  • Market Cap

    INR 97.73 Cr

  • Sales

    INR 36.54 Cr

  • Shares in Float

    0.86 Cr

  • No of Funds

    5 K

  • Yield

    %

  • Book Value

    6.06

  • U/D Vol Ratio

    0.9

  • LTDebt/Equity

    %

  • Alpha

    -0.66

  • Beta

    0.71

Biofil Chemicals & Pharmaceuticals Ltd Ownership
Biofil Chemicals & Pharmaceuticals Ltd Management

Biofil Chemicals & Pharmaceuticals Ltd Financials

INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Total ShareHolders Funds Annual Cr 16.129114.883113.649713.167412.6966
Fixed Assets Annual Cr 9.776910.092610.29429.24689.1645
Total Non Current Assets Annual Cr 9.776910.092610.29429.24689.1645
Total Current Assets Annual Cr 23.461532.272113.918814.907912.676
Total Assets Annual Cr 33.238442.364724.21324.154721.8405
INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Book Value Per Share Annual Rs 9.9119.1458.3878.0917.801
ROE Annual % 7.698.113.533.5714.13
ROCE Annual % 12.0510.655.555.6119.48
Total Debt to Total Equity Annual -----
EBDIT Annual Margin % 6.716.714.858.3720.49

Biofil Chemicals & Pharmaceuticals Ltd Technicals

EMA & SMA

CURRENT PRICE

60.05 (1.61)

    • Bullish Moving Averages 5
    • Bearish Moving Averages 11

EMA

  • 20 Day

    60.56

  • 50 Day

    62.35

  • 100 Day

    64.64

  • 200 Day

    68.86

Biofil Chemicals & Pharmaceuticals Ltd Resistance and support

59.84 PIVOT

  • First Resistance

    60.87

  • Second Resistance

    62.64

  • Third Resistance

    63.67

  • First Support

    58.07

  • Second Support

    57.04

  • Third Support

    55.27

  • RSI

    46.78

  • MFI

    35.27

  • MACD

    -1.06

  • MACD signal line

    -1.11

Biofil Chemicals & Pharmaceuticals Ltd Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 40,427 2,477,771 61.29%
Week 35,643 2,280,070 63.97%
1 Month 31,469 2,147,431 68.24%
6 Month 80,139 4,719,379 58.89%

Biofil Chemicals & Pharmaceuticals Ltd Price change analysis

-2.75

Over 1 month

Low High
54.45 64.95

-3.1

Over 3 month

Low High
54.45 75.55

-9.6

Over 6 months

Low High
54.45 92.15

-181.05

Over Year

Low High
54.45 356.1

Similar Stocks

News

BIOFIL CHEMICALS & PHARMACEUTICALS LTD. - 524396 - Resubmiss

Pursuant to Regulation 33(3)(d) of SEBI(LODR) Regulations, 2015, the Un-audited Financial Statements of the Company for the Quarter and Half Read More

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Announceme

Pursuant to Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed copies of Ext Read More

BIOFIL CHEMICALS & PHARMACEUTICALS LTD. - 524396 - Submissio

Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are hereby enc Read More

BIOFIL CHEMICALS & PHARMACEUTICALS LTD. - 524396 - Board Mee

With reference to the above captioned subject, we would like to inform that Board of Directors of the Company in their meeting held on today Read More

BIOFIL CHEMICALS & PHARMACEUTICALS LTD. - 524396 - Board Mee

BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 Read More

Blogs

FAQs